Working to Eradicate Gynecologic Cancers

Junzo Hamanishi, MD, PhD.

Department of Gynecology and Obstetrics
Kyoto University
54 Shogoin, Kawahara-cho
Sakyo-ku
Kyoto Japan 606-8507

Papers:
52 Durable anti-tumor response of nivolumab (anti-PD-1 antibody) for platinum-resistant ovarian cancer; phase II clinical trial with nivolumab